-
1
-
-
0034962780
-
Natural history of Alzheimer's disease
-
Honig LS, Mayeux R, (2001) Natural history of Alzheimer's disease. Aging 13: 171-182.
-
(2001)
Aging
, vol.13
, pp. 171-182
-
-
Honig, L.S.1
Mayeux, R.2
-
2
-
-
0030806911
-
Brain infarction and the clinical expression of Alzheimer disease
-
Roman GC, (1997) Brain infarction and the clinical expression of Alzheimer disease. JAMA. 9 278(2): 113-4.
-
(1997)
JAMA
, vol.278
, Issue.2
, pp. 113-114
-
-
Roman, G.C.1
-
3
-
-
63849176138
-
The role of tau in neurodegeneration
-
Gendron TF, Petrucelli L, (2009) The role of tau in neurodegeneration. Mol Neurodegener. 11 4: 13.
-
(2009)
Mol Neurodegener
, vol.11
, Issue.4
, pp. 13
-
-
Gendron, T.F.1
Petrucelli, L.2
-
4
-
-
0027420369
-
Tau protein and the neurofibrillary pathology of Alzheimer's disease
-
Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends in Neurosciences. 16 11: 460-465.
-
(1993)
Trends in Neurosciences
, vol.16
, Issue.11
, pp. 460-465
-
-
Goedert, M.1
-
5
-
-
19944375450
-
Tau pathology in Alzheimer disease and other tauopathies
-
Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, et al. (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta. 3 1739(2-3): 198-210.
-
(2005)
Biochim Biophys Acta
, vol.1739
, Issue.2-3
, pp. 198-210
-
-
Iqbal, K.1
Alonso Adel, C.2
Chen, S.3
Chohan, M.O.4
El-Akkad, E.5
-
6
-
-
37749047236
-
Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
-
Muyllaert D, Kremer A, Jaworski T, Borghgraef P, Devijver H, et al. (2008) Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Genes Brain Behav. 7 (Suppl 1): 57-66.
-
(2008)
Genes Brain Behav
, vol.7
, Issue.SUPPL. 1
, pp. 57-66
-
-
Muyllaert, D.1
Kremer, A.2
Jaworski, T.3
Borghgraef, P.4
Devijver, H.5
-
7
-
-
21044449225
-
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
-
Noble W, Planel E, Zehr C, Olm V, Meyerson J, et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 10 102(19): 6990-5.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.19
, pp. 6990-6995
-
-
Noble, W.1
Planel, E.2
Zehr, C.3
Olm, V.4
Meyerson, J.5
-
8
-
-
34250818767
-
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles
-
Caccamo A, Oddo S, Tran LX, LaFerla FM, (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol. 170(5): 1669-75.
-
(2007)
Am J Pathol
, vol.170
, Issue.5
, pp. 1669-1675
-
-
Caccamo, A.1
Oddo, S.2
Tran, L.X.3
LaFerla, F.M.4
-
9
-
-
0035066332
-
Alzheimer's disease: genes, proteins, and therapy
-
Selkoe DJ, (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 81(2): 741-66.
-
(2001)
Physiol Rev
, vol.81
, Issue.2
, pp. 741-766
-
-
Selkoe, D.J.1
-
10
-
-
79952747862
-
Alzheimer's disease
-
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al. (2011) Alzheimer's disease. Lancet. 19 377(9770): 1019-31.
-
(2011)
Lancet
, vol.377
, Issue.9770
, pp. 1019-1031
-
-
Ballard, C.1
Gauthier, S.2
Corbett, A.3
Brayne, C.4
Aarsland, D.5
-
11
-
-
0037010298
-
Beta-secretase as a target for the treatment of Alzheimer's disease
-
Citron M, (2002) Beta-secretase as a target for the treatment of Alzheimer's disease. J Neurosci Res. 70: 373-9.
-
(2002)
J Neurosci Res
, vol.70
, pp. 373-379
-
-
Citron, M.1
-
12
-
-
0035112647
-
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons
-
Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, et al. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 4: 233-4.
-
(2001)
Nat Neurosci
, vol.4
, pp. 233-234
-
-
Cai, H.1
Wang, Y.2
McCarthy, D.3
Wen, H.4
Borchelt, D.R.5
-
13
-
-
0036861132
-
Emerging Alzheimer's disease therapies: inhibition of beta-secretase
-
Citron M, (2002) Emerging Alzheimer's disease therapies: inhibition of beta-secretase. Neurobiol Aging. 23(6): 1017-22.
-
(2002)
Neurobiol Aging
, vol.23
, Issue.6
, pp. 1017-1022
-
-
Citron, M.1
-
14
-
-
77954051527
-
Identification of beta-secretase (BACE1) substrates using quantitative proteomics
-
Hemming ML, Elias JE, Gygi SP, Selkoe DJ, (2009) Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One. 29 4(12): e8477.
-
(2009)
PLoS One
, vol.4
, Issue.12
-
-
Hemming, M.L.1
Elias, J.E.2
Gygi, S.P.3
Selkoe, D.J.4
-
15
-
-
19644368873
-
Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies
-
Arbel M, Yacoby I, Solomon B, (2005) Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. Proc Natl Acad Sci USA 102: 7718-7723.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 7718-7723
-
-
Arbel, M.1
Yacoby, I.2
Solomon, B.3
-
16
-
-
34547215215
-
Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels
-
Rakover I, Arbel M, Solomon B, (2007) Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Neurodegener Dis. 4(5): 392-402.
-
(2007)
Neurodegener Dis
, vol.4
, Issue.5
, pp. 392-402
-
-
Rakover, I.1
Arbel, M.2
Solomon, B.3
-
17
-
-
78650825703
-
Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice
-
Arbel-Ornath M, Becker M, Rabinovich-Toidman P, Gartner M, Solomon B, (2010) Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice. J Alzheimers Dis. 22(2): 469-82.
-
(2010)
J Alzheimers Dis
, vol.22
, Issue.2
, pp. 469-482
-
-
Arbel-Ornath, M.1
Becker, M.2
Rabinovich-Toidman, P.3
Gartner, M.4
Solomon, B.5
-
18
-
-
0036468268
-
Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment
-
King DL, Arendash GW, (2002) Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res. 1 926(1-2): 58-68.
-
(2002)
Brain Res
, vol.926
, Issue.1-2
, pp. 58-68
-
-
King, D.L.1
Arendash, G.W.2
-
19
-
-
0028267440
-
Normal and abnormal biology of the beta-amyloid precursor protein
-
Selkoe DJ, (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci. 17: 489-517.
-
(1994)
Annu Rev Neurosci
, vol.17
, pp. 489-517
-
-
Selkoe, D.J.1
-
20
-
-
0024362050
-
Comparison of four staining methods on the detection of neuritic plaques
-
Wisniewski HM, Wen GY, Kim KS, (1989) Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol. 78(1): 22-7.
-
(1989)
Acta Neuropathol
, vol.78
, Issue.1
, pp. 22-27
-
-
Wisniewski, H.M.1
Wen, G.Y.2
Kim, K.S.3
-
21
-
-
63849176138
-
The role of tau in neurodegeneration
-
Gendron TF, Petrucelli L, (2009) The role of tau in neurodegeneration. Mol Neurodegener. 11 4: 13.
-
(2009)
Mol Neurodegener
, vol.11
, Issue.4
, pp. 13
-
-
Gendron, T.F.1
Petrucelli, L.2
-
22
-
-
0028593606
-
Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
-
Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, et al. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res. 15 39(6): 669-73.
-
(1994)
J Neurosci Res
, vol.39
, Issue.6
, pp. 669-673
-
-
Otvos Jr., L.1
Feiner, L.2
Lang, E.3
Szendrei, G.I.4
Goedert, M.5
-
23
-
-
0029998294
-
Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation
-
Wagner U, Utton M, Gallo JM, Miller CC, (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci. 109 (Pt 6): 1537-43.
-
(1996)
J Cell Sci
, vol.109
, Issue.Pt 6
, pp. 1537-1543
-
-
Wagner, U.1
Utton, M.2
Gallo, J.M.3
Miller, C.C.4
-
24
-
-
0034731461
-
Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
-
Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, et al. (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem. 29 275(52): 41340-9.
-
(2000)
J Biol Chem
, vol.275
, Issue.52
, pp. 41340-41349
-
-
Spittaels, K.1
van den Haute, C.2
Van Dorpe, J.3
Geerts, H.4
Mercken, M.5
-
25
-
-
0034612175
-
Inflammation and Alzheimer's disease
-
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging. 21(3): 383-421.
-
(2000)
Neurobiol Aging
, vol.21
, Issue.3
, pp. 383-421
-
-
Akiyama, H.1
Barger, S.2
Barnum, S.3
Bradt, B.4
Bauer, J.5
-
26
-
-
77949491472
-
Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease
-
Rodríguez JJ, Witton J, Olabarria M, Noristani HN, Verkhratsky A, (2010) Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis. 1(1): e1.
-
(2010)
Cell Death Dis
, vol.1
, Issue.1
-
-
Rodríguez, J.J.1
Witton, J.2
Olabarria, M.3
Noristani, H.N.4
Verkhratsky, A.5
-
27
-
-
0024824922
-
Patterns of gliosis in Alzheimer's disease and aging cerebrum
-
Beach TG, Walker R, McGeer EG, (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2(6): 420-36.
-
(1989)
Glia
, vol.2
, Issue.6
, pp. 420-436
-
-
Beach, T.G.1
Walker, R.2
McGeer, E.G.3
-
29
-
-
0042697305
-
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
-
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 31 39(3): 409-21.
-
(2003)
Neuron
, vol.39
, Issue.3
, pp. 409-421
-
-
Oddo, S.1
Caccamo, A.2
Shepherd, J.D.3
Murphy, M.P.4
Golde, T.E.5
-
30
-
-
27144511230
-
Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease
-
Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, et al. (2005) Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci. 5 25(40): 9096-101.
-
(2005)
J Neurosci
, vol.25
, Issue.40
, pp. 9096-9101
-
-
Buttini, M.1
Masliah, E.2
Barbour, R.3
Grajeda, H.4
Motter, R.5
-
31
-
-
78751644048
-
Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease
-
Ittner LM, Götz J, (2011) Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 12(2): 65-72.
-
(2011)
Nat Rev Neurosci
, vol.12
, Issue.2
, pp. 65-72
-
-
Ittner, L.M.1
Götz, J.2
-
32
-
-
73949142307
-
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
-
Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, et al. (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A. 24 106(47): 20057-62.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.47
, pp. 20057-20062
-
-
Rhein, V.1
Song, X.2
Wiesner, A.3
Ittner, L.M.4
Baysang, G.5
-
33
-
-
78650251838
-
Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration
-
Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, et al. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 22 68(6): 1067-81.
-
(2010)
Neuron
, vol.68
, Issue.6
, pp. 1067-1081
-
-
Hoover, B.R.1
Reed, M.N.2
Su, J.3
Penrod, R.D.4
Kotilinek, L.A.5
-
34
-
-
34250818767
-
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles
-
Caccamo A, Oddo S, Tran LX, LaFerla FM, (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol. 170: 1669-1675.
-
(2007)
Am J Pathol
, vol.170
, pp. 1669-1675
-
-
Caccamo, A.1
Oddo, S.2
Tran, L.X.3
LaFerla, F.M.4
-
35
-
-
0032850599
-
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
-
Pei JJ, Braak E, Braak H, Grunde-Iqbal I, Iqbal K, et al. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropath Exp Neurol 58, 1010-1019.
-
(1999)
J Neuropath Exp Neurol
, vol.58
, pp. 1010-1019
-
-
Pei, J.J.1
Braak, E.2
Braak, H.3
Grunde-Iqbal, I.4
Iqbal, K.5
-
36
-
-
0032590054
-
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
-
McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46, 860866.
-
(1999)
Ann Neurol
, vol.46
, pp. 860866
-
-
McLean, C.A.1
Cherny, R.A.2
Fraser, F.W.3
Fuller, S.J.4
Smith, M.J.5
-
37
-
-
25144501662
-
Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease
-
Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244.
-
(2005)
Neurobiol Aging
, vol.26
, pp. 1235-1244
-
-
Gouras, G.K.1
Almeida, C.G.2
Takahashi, R.H.3
-
38
-
-
0033622324
-
Intraneuronal Abeta42 accumulation in human brain
-
Gouras GK, Tsai J, Naslund J, Vincent B, EdgarM,et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156, 1520.
-
(2000)
Am J Pathol
, vol.156
, pp. 1520
-
-
Gouras, G.K.1
Tsai, J.2
Naslund, J.3
Vincent, B.4
Edgar, M.5
-
39
-
-
0036827031
-
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology
-
Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, et al. (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
-
(2002)
Am J Pathol
, vol.161
, pp. 1869-1879
-
-
Takahashi, R.H.1
Milner, T.A.2
Li, F.3
Nam, E.E.4
Edgar, M.A.5
-
40
-
-
33749521100
-
Intraneuronal beta amyloid aggregates neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation
-
Oakley H, Cole SL, Logan S, Maus E, Shao P, et al. (2006) Intraneuronal beta amyloid aggregates neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140.
-
(2006)
J Neurosci
, vol.26
, pp. 10129-10140
-
-
Oakley, H.1
Cole, S.L.2
Logan, S.3
Maus, E.4
Shao, P.5
-
41
-
-
78149488153
-
Amyloid-independent mechanisms in Alzheimer's disease pathogenesis
-
Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH, (2010) Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci. 2010 Nov 10 30(45): 14946-54.
-
(2010)
J Neurosci
, vol.30
, Issue.45
, pp. 14946-14954
-
-
Pimplikar, S.W.1
Nixon, R.A.2
Robakis, N.K.3
Shen, J.4
Tsai, L.H.5
-
42
-
-
33646133879
-
BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration
-
Yoon SY, Choi JE, Yoon JH, Huh JW, Kim DH, (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis. 22(2): 435-44.
-
(2006)
Neurobiol Dis
, vol.22
, Issue.2
, pp. 435-444
-
-
Yoon, S.Y.1
Choi, J.E.2
Yoon, J.H.3
Huh, J.W.4
Kim, D.H.5
-
43
-
-
33845324145
-
C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression
-
Kim HS, Kim EM, Lee JP, Park CH, Kim S, et al. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 17(13): 1951-3.
-
(2003)
FASEB J
, vol.17
, Issue.13
, pp. 1951-1953
-
-
Kim, H.S.1
Kim, E.M.2
Lee, J.P.3
Park, C.H.4
Kim, S.5
-
44
-
-
40249114794
-
Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing
-
Wen Y, Yu WH, Maloney B, Bailey J, Ma J, et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 13 57(5): 680-90.
-
(2008)
Neuron
, vol.57
, Issue.5
, pp. 680-690
-
-
Wen, Y.1
Yu, W.H.2
Maloney, B.3
Bailey, J.4
Ma, J.5
-
45
-
-
0038187674
-
GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
-
Phiel CJ, Wilson CA, Lee VM, Klein PS, (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature. 22 423(6938): 435-9.
-
(2003)
Nature
, vol.423
, Issue.6938
, pp. 435-439
-
-
Phiel, C.J.1
Wilson, C.A.2
Lee, V.M.3
Klein, P.S.4
-
46
-
-
34247187312
-
Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I
-
Flajolet M, He G, Heiman M, Lin A, Nairn AC, et al. (2007) Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I. Proc Natl Acad Sci U S A. 6. 104(10): 4159-64.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, Issue.10
, pp. 4159-4164
-
-
Flajolet, M.1
He, G.2
Heiman, M.3
Lin, A.4
Nairn, A.C.5
-
47
-
-
77953143687
-
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
-
Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D, (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 22 2(1): 1.
-
(2010)
Alzheimers Res Ther
, vol.2
, Issue.1
, pp. 1
-
-
Zotova, E.1
Nicoll, J.A.2
Kalaria, R.3
Holmes, C.4
Boche, D.5
-
48
-
-
81955164821
-
Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice
-
Devi L, Ohno M, (2012) Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Neurobiol Dis. 45(1): 417-24.
-
(2012)
Neurobiol Dis
, vol.45
, Issue.1
, pp. 417-424
-
-
Devi, L.1
Ohno, M.2
-
49
-
-
4644230845
-
A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade
-
Dolev I, Michaelson DM, (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A 21 101(38): 13909-14.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, Issue.38
, pp. 13909-13914
-
-
Dolev, I.1
Michaelson, D.M.2
-
50
-
-
44649090171
-
Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits
-
Belinson H, Lev D, Masliah E, Michaelson DM, (2008) Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J Neurosci. 30 28(18): 4690-701.
-
(2008)
J Neurosci
, vol.28
, Issue.18
, pp. 4690-4701
-
-
Belinson, H.1
Lev, D.2
Masliah, E.3
Michaelson, D.M.4
-
51
-
-
76149120867
-
Memantine improves cognition and reduces Alzheimer's like neuropathology in transgenic mice
-
Martinez-Coria M, Green KN, Billings LM, Kitazawa M, Albrecht M, (2010) Memantine improves cognition and reduces Alzheimer's like neuropathology in transgenic mice. Am J Pathol. 176(2): 870-80.
-
(2010)
Am J Pathol
, vol.176
, Issue.2
, pp. 870-880
-
-
Martinez-Coria, M.1
Green, K.N.2
Billings, L.M.3
Kitazawa, M.4
Albrecht, M.5
-
52
-
-
84864411864
-
Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)
-
Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E, (2012) Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res. 1 234(2): 334-42.
-
(2012)
Behav Brain Res
, vol.234
, Issue.2
, pp. 334-342
-
-
Filali, M.1
Lalonde, R.2
Theriault, P.3
Julien, C.4
Calon, F.5
Planel, E.6
|